通过HIF-1-介导的ISG20表达促进乳腺癌干细胞和免疫逃避
Yongkang Yang1,2, Qiaozhu Zuo1,3, Vijay Ramu4
1Armstrong Oxygen Biology Research Center and Institute for Cell Engineering, Johns Hopkins University School of Medicine , Baltimore, MD, USA.
The Journal of experimental medicine
|December 12, 2025
概括
在三阴性乳腺癌 (TNBC) 中针对ISG20显示出有希望. 抑制ISG20可能会提高免疫疗法的有效性,通过恢复免疫细胞活性来减少转移.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种具有侵略性且缺乏有效治疗方法的癌症.
- 缺氧诱导因子1 (HIF-1) 调节TNBC中的基因表达.
- ISG20是一种RNA外核酶,在TNBC中被HIF-1转录激活.
研究的目的:
- 研究ISG20在TNBC进展和免疫逃避中的作用.
- 确定是否针对ISG20可以提高免疫疗法的疗效.
主要方法:
- 研究了TNBC细胞中ISG20转录的HIF-1激活.
- 分析了ISG20对RHOBTB3,NANOG,STAT1和IRF1mRNA水平的影响.
- 评估ISG20对免疫细胞 (CD8+ T细胞,NK细胞) 招募的影响.
- 评估了ISG20沉默TNBC细胞对小鼠抗PD1治疗的敏感性.
主要成果:
- ISG20降解了RHOBTB3mRNA,增加了HIF-1α和NANOG信号,促进了茎和肺转移.
- ISG20降解STAT1和IRF1mRNA,减少CXCL10的表达,并影响CD8+T细胞和NK细胞的招募.
- 沉默ISG20增强TNBC细胞对抗PD1免疫检查点封锁的敏感性.
结论:
- 在TNBC的进展,转移和免疫逃避中,ISG20起着至关重要的作用.
- 针对ISG20与免疫治疗结合,代表了TNBC的潜在治疗策略.
相关概念视频
Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Induced Pluripotent Stem Cells
5.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.3K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K


